Mukherjee Biswajit, Mahapatra Sushmita, Gupta Ritu, Patra Balaram, Tiwari Amit, Arora Priyanka
Department of Pharmaceutical Technology, Jadavpur University, Kolkata (Calcutta), India.
Eur J Pharm Biopharm. 2005 Apr;59(3):475-83. doi: 10.1016/j.ejpb.2004.09.009.
The present study was designed to develop a suitable matrix type transdermal drug delivery system (TDDS) of dexamethasone using blends of two different polymeric combinations, povidone (PVP) and ethylcellulose (EC) and Eudragit with PVP. Physical studies including moisture content, moisture uptake, flatness to study the stability of the formulations and in vitro dissolution of the experimental formulations were performed to determine the amount of dexamethasone present in the patches were performed and scanning electron microscopy (SEM) photographs of the prepared TDDS were taken to see the drug distribution pattern. Drug-excipient interaction studies were carried out using Fourier transform infrared (FTIR) spectroscopic technique. In vitro skin permeation study was conducted in a modified Franz's diffusion cell. All the formulations were found to be suitable for formulating in terms of physicochemical characteristics and there was no significant interaction noticed between the drug and polymers used. In vitro dissolution studies showed that the drug distribution in the matrix was homogeneous and the SEM photographs further demonstrated this. The formulations of PVP:EC provided slower and more sustained release of drug than the PVP:Eudragit formulations during skin permeation studies and the formulation PVP:EC (1:5) was found to provide the slowest release of drug. Based on the above observations, it can be reasonably concluded that PVP-EC polymers are better suited than PVP-Eudragit polymers for the development of TDDS of dexamethasone.
本研究旨在使用两种不同聚合物组合(聚维酮(PVP)与乙基纤维素(EC))以及 Eudragit 与 PVP 的混合物,开发一种合适的地塞米松基质型透皮给药系统(TDDS)。进行了包括水分含量、吸湿量、平整度等物理研究以考察制剂的稳定性,对实验制剂进行体外溶出度研究以测定贴剂中地塞米松的含量,并拍摄制备的 TDDS 的扫描电子显微镜(SEM)照片以观察药物分布模式。使用傅里叶变换红外(FTIR)光谱技术进行药物 - 辅料相互作用研究。在改良的 Franz 扩散池中进行体外皮肤渗透研究。发现所有制剂在物理化学特性方面都适合进行制剂开发,并且所使用的药物与聚合物之间未观察到明显的相互作用。体外溶出度研究表明药物在基质中的分布是均匀的,SEM 照片进一步证明了这一点。在皮肤渗透研究中,PVP:EC 制剂比 PVP:Eudragit 制剂提供更缓慢且更持久的药物释放,并且发现制剂 PVP:EC(1:5)提供的药物释放最慢。基于上述观察结果,可以合理地得出结论,对于地塞米松 TDDS 的开发,PVP - EC 聚合物比 PVP - Eudragit 聚合物更合适。